Branded Legacy Inc (BLEG)
| Previous Close | 0.0013 |
| Open | 0.0013 |
| Bid | 0.0013 x 0 |
| Ask | 0.0014 x 0 |
| Day's Range | 0.0013 - 0.0014 |
| 52 Week Range | 0.0010 - 0.0060 |
| Volume | |
| Avg. Volume | 5,880,260 |
| Market Cap | 1.197M |
| Beta (5Y Monthly) | 1.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireBranded Legacy, Inc. Secures Key Client with $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025
Branded Legacy, Inc.,(OTC.PK: BLEG) a leading supplier of botanical extracts and alkaloid-based compounds, is excited to announce that it has sent its first invoice to Monster Group, Inc. a multinational product manufacturer and distributor generating over $70,000,000 in annual revenue. This partnership marks a significant milestone and is expected to act as a catalyst that will propel Branded Legacy into generating over $10,000,000 annually in revenue by 2025.
PR NewswireFifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement
Fifty 1 Labs, Inc. (OTC-PINK: CAFI), a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries, and All-In-Extracts, a wholly owned subsidiary of Royal Biotek Enterprises (OTC-PINK: BLEG) and a renowned provider of high-quality botanical extracts, are excited to announce a strategic joint venture to develop and release a groundbreaking testosterone-boosting supplement under Fifty 1 Labs wholly owned subsidiary, 51 Labs, LLC. Clinical trials f
